These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 8542914

  • 1. Comparison of subcutaneous sumatriptan with usual acute treatments for migraine. French Sumatriptan Study Group.
    Boureau F, Chazot G, Emile J, Bertin L, d'Allens H.
    Eur Neurol; 1995; 35(5):264-9. PubMed ID: 8542914
    [Abstract] [Full Text] [Related]

  • 2. An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan.
    Landy SH, Tepper SJ, Wein T, Schweizer E, Ramos E.
    Headache; 2013 Jan; 53(1):118-125. PubMed ID: 23148799
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group.
    Diener HC.
    Cephalalgia; 1999 Jul; 19(6):581-8; discussion 542. PubMed ID: 10448545
    [Abstract] [Full Text] [Related]

  • 4. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.
    Laloux P, Vakaet A, Monseu G, Jacquy J, Bourgeois P, van der Linden C.
    Acta Neurol Belg; 1998 Dec; 98(4):332-41. PubMed ID: 9922821
    [Abstract] [Full Text] [Related]

  • 5. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group.
    Eur Neurol; 1991 Dec; 31(5):323-31. PubMed ID: 1653140
    [Abstract] [Full Text] [Related]

  • 6. Introduction of a novel self-injector for sumatriptan. A controlled clinical trial in general practice.
    Jensen K, Tfelt-Hansen P, Hansen EW, Krøis EH, Pedersen OS.
    Cephalalgia; 1995 Oct; 15(5):423-9. PubMed ID: 8536304
    [Abstract] [Full Text] [Related]

  • 7. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [Abstract] [Full Text] [Related]

  • 8. Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from the COMPASS Study.
    Lipton RB, McGinley JS, Shulman KJ, Wirth RJ, Buse DC.
    Headache; 2017 Nov; 57(10):1570-1582. PubMed ID: 28880380
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: an 8-week open-label extension study.
    Landy S, Munjal S, Brand-Schieber E, Rapoport AM.
    J Headache Pain; 2018 Aug 15; 19(1):70. PubMed ID: 30112725
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study.
    Sandrini G, Cerbo R, Del Bene E, Ferrari A, Genco S, Grazioli I, Martelletti P, Nappi G, Pinessi L, Sarchielli P, Tamburro P, Uslenghi C, Zanchin G.
    Int J Clin Pract; 2007 Aug 15; 61(8):1256-69. PubMed ID: 17627707
    [Abstract] [Full Text] [Related]

  • 11. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
    Göbel H, Heinze A, Stolze H, Heinze-Kuhn K, Lindner V.
    Cephalalgia; 1999 Sep 15; 19(7):676-83; discussion 626. PubMed ID: 10524662
    [Abstract] [Full Text] [Related]

  • 12. Long-term efficacy of subcutaneous sumatriptan using a novel self-injector.
    Gross ML, Kay J, Turner AM, Jewsbury J, Cleal AL.
    Headache; 1995 Sep 15; 35(10):601-6. PubMed ID: 8550361
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache.
    Cull RE, Price WH, Dunbar A.
    J Neurol Neurosurg Psychiatry; 1997 May 15; 62(5):490-5. PubMed ID: 9153607
    [Abstract] [Full Text] [Related]

  • 14. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G, Valette C.
    Rev Neurol (Paris); 2000 Jul 15; 156(6-7):646-53. PubMed ID: 10891800
    [Abstract] [Full Text] [Related]

  • 15. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device: comparison with customary treatment in an open, longitudinal study.
    Schoenen J, Bulcke J, Caekebeke J, Dehaene I, De Keyser J, Hildebrand G, Joffroy A, Laloux P, Louis P, Monseu G.
    Cephalalgia; 1994 Feb 15; 14(1):55-63. PubMed ID: 8200027
    [Abstract] [Full Text] [Related]

  • 16. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group.
    Savani N, Brautaset NJ, Reunanen M, Szirmai I, Ashford EA, Hassani H, Saiers J.
    Int J Clin Pract Suppl; 1999 Aug 15; 105():7-15. PubMed ID: 10692717
    [Abstract] [Full Text] [Related]

  • 17. Headache medication-use among primary care headache patients in a health maintenance organization.
    Von Korff M, Black LK, Saunders K, Galer BS.
    Cephalalgia; 1999 Jul 15; 19(6):575-80; discussion 541-2. PubMed ID: 10448544
    [Abstract] [Full Text] [Related]

  • 18. A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine.
    Touchon J, Bertin L, Pilgrim AJ, Ashford E, Bès A.
    Neurology; 1996 Aug 15; 47(2):361-5. PubMed ID: 8757005
    [Abstract] [Full Text] [Related]

  • 19. Efficacy, tolerability, and patient satisfaction with 50- and 100-mg sumatriptan tablets in those initially dissatisfied with the efficacy of 50-mg sumatriptan tablets.
    Savani N, Pfaffenrath V, Rice L, Boswell D, Black L, Jones M, Sumatriptan SUMB4007 Study Group.
    Clin Ther; 2001 Feb 15; 23(2):260-71. PubMed ID: 11293559
    [Abstract] [Full Text] [Related]

  • 20. An open study of self-administration of subcutaneous sumatriptan to treat successive attacks of acute migraine. Portuguese Sumatriptan Auto-injector Study Group.
    J Int Med Res; 1994 Feb 15; 22(4):225-35. PubMed ID: 7958382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.